ENGERIX-B
NDC 58160-820, Hepatitis B Vaccine (Recombinant), injection, suspension, from GlaxoSmithKline Biologicals SA.
- Product NDC
- 58160-820
- Status
- Listed
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103239
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58160-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN10 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58160-820-52 | 58160082052 | 10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58160-820 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58160-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58160-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.